...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Updates
1
Jan 29, 2016 10:52AM
6
Jan 29, 2016 12:50PM
5
Jan 30, 2016 10:49AM

And, with a successful IND and a Phase I about to start, the company is in a much stronger position to negotiate. Contrast that with 2014 when the company suspended clinical development of ZEN-3365.

5
Jan 30, 2016 01:05PM
7
Feb 02, 2016 02:53PM
3
Feb 02, 2016 07:02PM
3
Feb 02, 2016 07:40PM
6
Feb 02, 2016 10:41PM
4
Feb 03, 2016 08:41AM

Feb 03, 2016 09:08AM
3
Feb 03, 2016 11:09AM
2
Feb 03, 2016 12:21PM
Share
New Message
Please login to post a reply